Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
1.65
Jun. 30, 2025 16:00:01- Change 0.23 (16.19718%)
- Volume 1,044,758
- Today's Open 1.45
- Previous Close 1.42
- Today's High 1.69
- Today's Low 1.45
- 52 Week High 4.3
- 52 Week Low 0.85